Is Asia-Pacific on track towards elimination of Malaria by 2030?, PgII

Key Highlights:

• The World Malaria Report 2025 indicates mixed progress towards malaria elimination by 2030, with successes in Southeast Asia offset by rising drug resistance and funding shortfalls.
• Asia-Pacific saw a reduction in estimated malaria cases from 9.6 million in 2023 to approximately 8.9 million in 2024, driven by progress in countries like Pakistan, Cambodia, Lao PDR, and Vietnam.
• The Asia Pacific Leaders Malaria Alliance (APLMA) unites 22 governments committed to eliminating malaria by 2030, but progress remains uneven across the region.
• India aims to eliminate indigenous malaria cases by 2027, but recent data suggests progress has plateaued, requiring enhanced surveillance and focused interventions in high-burden states.
• Malaria vaccines like RTS,S and R21 are being evaluated for targeted implementation in the Asia Pacific region to complement existing malaria control tools.

Detailed Insights:

• The Greater Mekong Subregion has shown success in tackling antimalarial drug resistance, a crucial emerging threat, while artemisinin resistance has not yet been established in India.
• India's strategy to preserve drug efficacy includes universal parasitological diagnosis, strict adherence to combination therapy, and avoidance of oral artemisinin monotherapy.
• Effective malaria elimination requires a shift towards making surveillance the central intervention, including real-time, case-based reporting from all sectors.
• Focused execution in high-burden states and preventing resurgence in near-elimination states are crucial for India to achieve its 2027 target.
• Declining international funding for malaria programs is a major threat, necessitating increased national investment and innovative financing models.
• Mobile, migrant populations and geographically remote communities in Asia Pacific are particularly vulnerable due to limited access to health services.
• Investing in malaria elimination yields economic returns through reduced healthcare costs, increased productivity, and stronger community resilience.

Key Concepts Involved:

• Artemisinin Resistance: The ability of malaria parasites to survive treatment with artemisinin-based drugs.
• Surveillance: The systematic collection, analysis, and interpretation of data for planning, implementation, and evaluation of public health practice.
• Vector Control: Methods used to limit or eradicate the mosquitoes that transmit malaria.